Sharper & Granite’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
12,648
-1,235
| -9% | -$105K | 0.41% | 65 |
|
|
2025
Q1 | $1.13M | Buy |
13,883
+1,830
| +15% | +$148K | 0.47% | 58 |
|
|
2024
Q4 | $1.09M | Buy |
12,053
+380
| +3% | +$34.2K | 0.48% | 59 |
|
|
2024
Q3 | $1.15M | Sell |
11,673
-350
| -3% | -$34.6K | 0.51% | 56 |
|
|
2024
Q2 | $1.11M | Buy |
12,023
+110
| +0.9% | +$10.2K | 0.53% | 56 |
|
|
2024
Q1 | $1.07M | Sell |
11,913
-107
| -0.9% | -$9.65K | 0.52% | 56 |
|
|
2023
Q4 | $1.07M | Buy |
12,020
+565
| +5% | +$50.4K | 0.56% | 54 |
|
|
2023
Q3 | $836K | Buy |
11,455
+660
| +6% | +$48.2K | 0.49% | 62 |
|
|
2023
Q2 | $898K | Buy |
10,795
+810
| +8% | +$67.4K | 0.52% | 58 |
|
|
2023
Q1 | $761K | Buy |
9,985
+595
| +6% | +$45.3K | 0.46% | 63 |
|
|
2022
Q4 | $779K | Buy |
+9,390
| New | +$779K | 0.52% | 57 |
|